Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 0 | 1,000 | 346 | 0 | 0 |
| Cost of Goods | N/A | 350 | N/A | N/A | N/A |
| Gross Profit | N/A | 650 | 346 | N/A | N/A |
| Operating Expenses | 9,380 | 9,008 | 20,937 | 49,652 | 14,872 |
| Operating Income | -9,380 | -8,008 | -20,591 | -46,652 | -14,872 |
| Interest Expense | 157 | 200 | 201 | 53 | 683 |
| Other Income | 3,103 | 4,111 | -1,252 | 22 | 8,511 |
| Pre-tax Income | -6,434 | -4,097 | -22,044 | -46,683 | -7,044 |
| Net Income Continuous | -6,434 | -4,097 | -22,044 | -46,683 | -7,044 |
| Net Income | $-6,434 | $-4,097 | $-22,044 | $-46,683 | $-7,044 |
| EPS Basic Total Ops | -1.00 | -1.36 | -3.80 | -11.59 | -1.80 |
| EPS Basic Continuous Ops | -1.00 | -0.71 | -3.80 | -11.59 | -1.80 |
| EPS Diluted Total Ops | -1.00 | -1.36 | -3.80 | -11.59 | -1.80 |
| EPS Diluted Continuous Ops | -1.00 | -0.71 | -3.80 | -11.59 | -1.80 |
| EBITDA(a) | $-8,295 | $-6,638 | $-19,478 | $-48,456 | $-13,788 |